Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Sell
33
AMLX Quote, Financials, Valuation and Earnings
Last price:
$3.77
Seasonality move
:
-28.38%
Day range:
$3.61 - $3.79
52-week range:
$1.58 - $7.27
Dividend yield:
0%
P/E ratio:
21.03x
P/S ratio:
2.95x
P/B ratio:
2.03x
Volume:
402.5K
Avg. volume:
742.2K
1-year change:
37.96%
Market cap:
$334.9M
Revenue:
$87.4M
EPS (TTM):
-$4.44
Earnings Data
Next earnings date for AMLX
May 09
2025
Most recent earnings per share
-$0.55
Beat by $0.04
(Mar 4/2025)
Consensus Estimate
-$0.59
(Mar 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AMLX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | -- | -- | -- | -$0.55 | -- |
| 03/04/2025 | Q4 | -- | -$665K | -$0.55 | -$0.59 | $0.04 |
| 11/07/2024 | Q3 | -- | $416K | -$1.07 | -$0.92 | -$0.16 |
| 08/08/2024 | Q2 | $8.5M | -$1M | -$1.07 | -$0.82 | -$0.25 |
| 05/09/2024 | Q1 | $98.3M | $88.6M | -$1.75 | -$0.01 | -$1.74 |
| 02/22/2024 | Q4 | $107M | $108.4M | $0.07 | $0.23 | -$0.16 |
| 11/09/2023 | Q3 | $113.7M | $102.7M | $0.30 | $0.44 | -$0.14 |
| 08/10/2023 | Q2 | $92.1M | $98.2M | $0.31 | $0.07 | $0.24 |
| 05/11/2023 | Q1 | $59.7M | $71.4M | $0.02 | -$0.25 | $0.27 |
| 03/13/2023 | Q4 | $4.7M | $21.9M | -$0.65 | -$0.84 | $0.19 |
| 11/10/2022 | Q3 | $83.3K | $345K | -$0.92 | -$0.98 | $0.06 |
| 08/11/2022 | Q2 | -- | -- | -$0.93 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.93 | -- | -- |
| 03/30/2022 | Q4 | -- | -- | -$0.51 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.42 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.48 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.32 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.19 | -- | -- |
Amylyx Pharmaceuticals Earnings Questions
-
How Much did Amylyx Pharmaceuticals Generate in Revenue Last Quarter?
Amylyx Pharmaceuticals reported -$665K worth of top line sales in its most recent quarter.
-
Did Amylyx Pharmaceuticals Beat Earnings Last Quarter?
Amylyx Pharmaceuticals announced earnings per share of -$0.55 which represents a beat of analyst forecast a -$0.59 per share.
-
Is Amylyx Pharmaceuticals Profitable?
Amylyx Pharmaceuticals reported -$665K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Amylyx Pharmaceuticals EPS Next Year?
Amylyx Pharmaceuticals's earnings are forecast to decrease from -$4.43 per share to -$4.30 per share next year representing a decrease of -48.98%.
-
When is Amylyx Pharmaceuticals's Earnings Date?
Amylyx Pharmaceuticals's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 1.01% over the past day.
Sell
36
MPTI alert for Mar 25
M-Tron Industries [MPTI] is up 7.48% over the past day.
